Article
Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin.
BMC microbiology - 15 Jan 2009
Zaczek Anna, Brzostek Anna, Augustynowicz-Kopec Ewa, Zwolska Zofia, Dziadek Jaroslaw
Abstract excerpt
BACKGROUND: Rifampin is a first line antituberculosis drug active against bacilli in logarithmic and stationary phase, which interferes with RNA synthesis by binding to bacterial RNA polymerase. Tubercle bacilli achieve resistance to rifampin by accumulation of mutations in a short-81 bp region of the rpoB gene. Among many mutations identified in the rpoB gene, few were verified by molecular genetic methods as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
